Ms Anoeska Schipper – Invited Speaker Series
The Haemoglobinopathies in European Liaison of Medicine and Science (HELIOS) network will host a monthly speaker series with established researchers presenting a new approach to the diagnosis, treatment, guidelines and health economics of haemoglobinopathies.
The HELIOS network is committed to ensuring equal access to training on haemoglobinopathies for all.
The fourth speaker in the webinar series is Dr Anoeska Schipper, PhD candidate at Radboud University Medical Center in Nijmegen.
We invite you to join us for this exciting opportunity to engage with the latest research in the field of haemoglobinopathies.
The speaker series is free of charge.
Additional Details
Speaker -
Speaker.
Anoeska Schipper is a PhD candidate at Radboud University Medical Center in Nijmegen, the Netherlands, conducting research at the Imaging Department and the Diagnostic Image Analysis Group (DIAG). Her work integrates artificial intelligence and natural language processing to enhance early diagnostic decision-making using routine test results. In her first study, she developed a machine learning model that automatically detects a broad range of hemoglobinopathies using routine blood counts from eight laboratories in the Netherlands and Spain. This model is now being implemented in laboratory information system. Before her PhD, she spent 7.5 years at Deloitte in IT forensics, developing AI-based tools for text classification and anomaly detection. This combination of research and industry experience positions Anoeska at the cutting edge of AI-driven diagnostic support.
Organizer
Stephanie Muth will host the monthly speaker series. Stephanie has worked for different medical device companies since 2010, breaking down barriers to introduce new treatment options to patients. She is passionate about collaborating with interdisciplinary stakeholders to improve the diagnosis and care available to patients. Since March 2022, Stephanie works with Resonance Health who provide FerriScan, the gold standard for liver iron concentration (LIC) measurements in haemoglobinopathy patients.